13F Data
13F filer · CIK 1395064

TAKEDA PHARMACEUTICAL CO LTD

Tokyo, M0 · filing since Q4 2023 · last filing Nov 13, 2025
Reported value
$16.4M
$-3.2M vs prior
Positions
8
New / sold out
0 / 3
Added / reduced
1 / 0
Turnover
1.2%
buys $222.8K · sells $13.9M
Top-10 weight
100.0%

Biggest buys vs Q2 2025

ChangeSecurityShares changeChange %Est. trade value
AddedLyell Immunopharma, Inc.+13,722+33.3%+$222.8K

Biggest sells vs Q2 2025

ChangeSecurityShares changeChange %Est. trade value
Sold outHilleVax, Inc.-6,724,000-100.0%$-13.4M
Sold outTurnstone Biologics-895,824-100.0%$-321.6K
Sold outThird Harmonic Bio, Inc.-36,835-100.0%$-200.0K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2023: $327.5MQ1 2024: $289.0MQ2 2024: $232.3MQ3 2024: $38.0MQ4 2024: $26.6MQ1 2025: $16.2MQ2 2025: $19.6MQ3 2025: $16.4M
Q4 2023Q3 2025

Holdings · Q3 2025

#SecuritySharesValueWeight
1Ovid Therapeutics, Inc.COM7,531,996$9.8M59.82%
2Equillium, Inc.COM1,824,977$2.6M15.94%
3Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)COM1,475,121$1.2M7.59%
4Shattuck Labs, Inc.COM515,619$1.2M7.53%
5Lyell Immunopharma, Inc.COM54,887$891.4K5.45%
6American Well CorporationCOM77,733$478.1K2.92%
7Rani Therapeutics Holdings, Inc.COM203,190$101.6K0.62%
8Standard Biotools, Inc.COM16,515$21.5K0.13%